Mark A. Velleca G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

Mark A. Velleca is of G1 Therapeutics, Inc.. Currently has a direct ownership of 116,000 shares of GTHX, which is worth approximately $829,400. The most recent transaction as insider was on Dec 16, 2020, when has been sold 10,000 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $37,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
0% 3M change
0% 12M change
Total Value Held $829,400

Mark A. Velleca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2020
BUY
Exercise of conversion of derivative security
$37,200 $3.72 p/Share
10,000 Added 17.54%
47,000 Common Stock
Dec 15 2020
SELL
Open market or private sale
$194,300 $19.43 p/Share
10,000 Reduced 21.28%
37,000 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$37,200 $3.72 p/Share
10,000 Added 17.54%
47,000 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
PRESIDENT & CEO
MAV

Mark A. Velleca

Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX